AHD-CLINICAL-004 — IV Library v0.1
Status: DRAFT v0.1 (REPLACED BY v1.0 protocols in AHD-RESEARCH-SYNTHESIS-v1.0 §SEAT 04)
v1.0 IV Library (from NEXUS clinical research)
Protocol IV-01: Wernicke Prevention Infusion (WPI)
- Composition: Thiamine 500mg in 100mL normal saline
- Indication: All AUD presentations
- Dose: 500mg IV TDS Day 1, reducing to BD Day 2-3 if no Wernicke signs
- Rate: Over 30 minutes
- Evidence: HIGH (RCP/NICE CG100)
Protocol IV-02: Targeted Rehydration + Electrolytes
- Composition: Normal saline 500mL-1L with KCl 20mmol if K<3.5
- Indication: Clinical dehydration only (NOT routine)
- Evidence: HIGH (targeted), LOW (routine)
Protocol IV-03: Magnesium Repletion (4g IV)
- Indication: Hypomagnesaemia in AUD
- Rate: Over 30-60 minutes
- Evidence: HIGH
Protocol IV-04: Modified Rally Pack
- Composition: Thiamine 100mg + folate 1mg + Mg 2g + multivitamin in 1L NS
- Indication: Daily nutritional support Day 2-5
- Evidence: MEDIUM (banana bag thiamine subtherapeutic alone)
Protocol IV-05: Glutathione Push
- Composition: 600-1200mg in 10-50mL NS
- Indication: Hepatic impairment, elevated LFTs
- Frequency: 2-3x weekly
- Evidence: LOW (NAFLD pilot data only)
Protocol IV-06: NAD+ Loading Infusion
- Composition: NAD+ 250-500mg in 250mL NS
- Indication: Post-acute Day 4+ in AUD/OUD
- Rate: SLOW, 4-6 hours
- Evidence: LOW (no RCTs); MEDIUM (safety + mechanism)
Protocol IV-07: Methylated B-Complex Push
- Composition: Methylcobalamin 1mg + methylfolate 1mg + B6 50mg + B2/B5
- Indication: Day 2+ general
- Evidence: MEDIUM
Protocol IV-08: Vitamin C High-Dose
- Composition: 2-5g in 100mL NS
- Indication: Optional adjunct, high oxidative stress
- Frequency: Every 2-3 days
- Evidence: LOW
Defensible Marketing Claims (per NEXUS clinical evidence research)
- “IV NAD+ provides mitochondrial cofactor repletion during a period when chronic substance use has depleted cellular energy substrates.”
- “Thiamine repletion is clinically established to prevent Wernicke encephalopathy in alcohol-dependent patients.”
- “Glutathione infusion supports hepatic antioxidant capacity during alcohol detoxification.”
Claims to AVOID
- “Evidence-based NAD+ treatment”
- “NAD+ eliminates withdrawal symptoms”
- “NAD+ rewires the brain’s reward pathways”
- “Endorsed by addiction medicine specialists”